WuXi AppTec appointed Edward Hu as co-CEO of the pharmaceutical and medical device technology company where he will share business management responsibilities with the company’s founder and CEO Ge Li. Since joining the company in 2007, Hu has served as its chief operating officer, chief financial officer and chief investment officer. Before joining WuXi, he served as senior vice president and chief operating officer at Tanox. Wuxi’s laboratory testing division is currently constructing a state-of-the-art test facility in the industrial hub of Suzhou, China.
Connecticut-based Lumendi named Michael R. Thomas as its new vice president of sales. Thomas has more than 30 years of experience in medical and surgical sales. He will be responsible for sales of the company’s DiLumen EIP and DiLumen C2 platforms that enable minimally invasive endolumenal therapies. He previously served as vice president of global sales and business development at bariatric surgical platform developer USGI Medical. Prior to that role, he served as bariatric practice advisor at Allergan, field marketing manager at Ethicon Endo-Surgery, senior professional representative at Fujisawa Pharmaceutical and regional trainer and recruiter at SmithKlineBeecham Pharma.